Title : Everolimus.

Pub. Date : 2010 Mar 1

PMID : 20179227






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Everolimus, an orally administered rapamycin analog, has recently been approved by the U.S. Food and Drug Administration for treatment of renal cell carcinoma (RCC) refractory to inhibitors of vascular endothelial growth factor (VEGF) receptor signaling. Sirolimus vascular endothelial growth factor A Homo sapiens